• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Apellis Pharmaceuticals

Paragliding over the cliffs Fort Funston San Francisco
Biotech

Apellis COO stepping down to take first CEO job—Chutes & Ladders

Apellis COO stepping down to take first CEO job. Egle, en route to the clinic, plucks a CEO. Neomorph nabs Boundless CMO.
Darren Incorvaia , Zoey Becker Jan 17, 2025 8:30am
A person in a grey sweater rubs their eyes Dry eye disease can cause a wide range of symptoms including pain blurry vision

Bausch + Lomb pens $485M-plus biobucks pact with City Tx

Jan 10, 2025 6:37am
parachutes peru

Another Biogen exec hitches ride to Voyager —Chutes & Ladders

Mar 15, 2024 9:30am
Apellis

Apellis lays off 25%, trims pipeline to free up cash for Syfovre

Aug 29, 2023 10:15am
eye see vision pupil eyelash

Annexon eye disease med failed phase 2 goal—the CEO is thrilled

May 24, 2023 4:01pm
Parachute

New year, new C-suite execs—Chutes & Ladders

Jan 6, 2023 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings